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ABSTRACT
Efficientosteogenicdifferentiationandboneformationfrommesenchymalstemcells(MSCs)shouldhaveclinicalapplicationsintreating
nonunion fracture healing. MSCs are adherent bone marrow stromal cells that can self-renew and differentiate into osteogenic,
chondrogenic, adipogenic, and myogenic lineages. We have identified bone morphogenetic protein 9 (BMP-9) as one of the most
osteogenicBMPs. Hereweinvestigate theeffectofinsulin-likegrowthfactor 2(IGF-2)onBMP-9-induced boneformation.Wehavefound
that endogenous IGF-2 expression is low in MSCs. Expression of IGF-2 can potentiate BMP-9-induced early osteogenic marker alkaline
phosphatase (ALP) activity and the expression of later markers. IGF-2 has been shown to augment BMP-9-induced ectopic bone
formation in the stem cell implantation assay. In perinatal limb explant culture assay, IGF-2 enhances BMP-9-induced endochondral
ossification, whereas IGF-2 itself can promote the expansion of the hypertropic chondrocyte zone of the cultured limb explants.
Expression of the IGF antagonists IGFBP3 and IGFBP4 leads to inhibition of the IGF-2 effect on BMP-9-induced ALP activity and matrix
mineralization. Mechanistically, IGF-2 is further shown to enhance the BMP-9-induced BMPR-Smad reporter activity and Smad1/5/8
nuclear translocation. PI3-kinase (PI3K) inhibitor LY294002 abolishes the IGF-2 potentiation effect on BMP-9-mediated osteogenic
signaling and can directly inhibit BMP-9 activity. These results demonstrate that BMP-9 crosstalks with IGF-2 through PI3K/AKT signaling
pathway during osteogenic differentiation of MSCs. Taken together, our findings suggest that a combination of BMP-9 and IGF-2 may be
exploredasaneffectivebone-regenerationagenttotreatlargesegmentalbonydefects,nonunionfracture,and/orosteoporoticfracture.
 2010 American Society for Bone and Mineral Research.
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Introduction
B
one is one of a few organs that retain the potential for
regeneration into adult life and is the only tissue that can
undergo continual remodeling throughout life. Osteogenesis is a
sequential cascade that recapitulates most, if not all, of the
cellular events occurring during embryonic skeletal develop-
ment.
(1) During skeletogenesis, bone formation can occur
through two different pathways, intramembranous ossification
and endochondral ossification.
(1) Bone regeneration following
a fracture progresses through sequential phases similar
to endochondral ossification, starting with chemotaxis and
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2447proliferation of mesenchymal stem cells. Efficacious bone
regeneration would have an important impact on the clinical
management of many bone and musculoskeletal disorders, such
as with segmental bone loss, fracture nonunion, osteoporotic
fracture, and failed spinal fusion. Mesenchymal stem cells (MSCs)
hold great promise for tissue bioengineering and regenerative
medicine. MSCs are adherent marrow stromal cells that can self-
renew and differentiate into osteogenic, chondrogenic, adipo-
genic, and myogenic lineages.
(2–4) Several signaling pathways
have been implicated in regulating stem cell self-renewal and
lineage commitment.
(5–8)
Bonemorphogeneticproteins(BMPs)playanimportantrolein
regulating cell proliferation and differentiation during develop-
ment
(8–11) and have been shown to play an important role in
stem cell biology.
(12,13) BMPs belong to the transforming growth
factor b (TGF-b) superfamily and consist of at least 15 members
in humans.
(8–11,14) Genetic disruptions of BMPs have resulted in
various skeletal and extraskeletal abnormalities during devel-
opment.
(14,15) BMPs fulfill their signaling activity by interacting
with the heterodimeric complex of two transmembrane serine/
threonine kinase receptors, BMPR type I and BMPR type II.
(9) The
activated receptor kinases phosphorylate the transcription
factors Smads 1, 5, or 8, which, in turn, form a heterodimeric
complex with Smad4 in the nucleus and activate the expression
of target genes in concert with other coactivators.
(9) On
analyzing the 14 types of BMPs, we found that BMP-9 is one
of the most potent BMPs in inducing osteogenic differentiation
of MSCs both in vitro and in vivo.
(11,16–22) We further
demonstrated that BMP-9 regulates a distinct set of downstream
targets that may play a role in regulating BMP-induced
osteoblast differentiation of MSCs.
(11,18–21)
BMP-9 (also known as growth differentiation factor 2,o rGDF-2)
was first identified in the developing mouse liver,
(23) and its
possible roles include inducing and maintaining the cholinergic
phenotype of embryonic basal forebrain cholinergic neurons,
(24)
inhibiting hepatic glucose production and inducing the
expression of key enzymes of lipid metabolism,
(25) and stimu-
lating murine hepcidin 1 expression.
(26) Although the functional
role of BMP-9 in the skeletal system remains to be fully
understood, the potent osteogenic activity of BMP-9 suggests
that it may be used as an efficacious bone-regeneration agent. It
is conceivable that other growth factors may act synergistically
or enhance BMP-9-induced bone formation.
Here we sought to investigate the effect of insulin-like growth
factor 2 (IGF-2) on BMP-9-induced bone formation. As a member
of the IGF signaling system, IGF-2 plays an important role in
prenatal growth and development.
(27) IGF-2 transduces its
signaling through IGF receptors and activates the phosphatidy-
linositol-3-kinase (PI3K)/AKT pathway or the mitogen-activated
protein kinase (MAPK) pathway.
(28) Igf2 null mice exhibit a 40%
decrease in birth weight compared with their wild-type
littermates, suggesting an important role of IGF-2 in develop-
ment.
(29,30) We have found that endogenous IGF-2 expression is
relatively low in MSCs. Exogenous expression of IGF-2 can
potentiate BMP-9-induced early osteogenic marker alkaline
phosphatase (ALP) activity and the expression of later markers,
such as osteocalcin (OC) and osteopontin (OPN), in MSCs. IGF-2 is
shown to augment BMP-9-induced ectopic bone formation in
stem cell implantation studies. Using perinatal limb explant
culture, we have demonstrated that IGF-2 enhances BMP-9-
induced endochondral ossification, whereas IGF-2 itself can
promote expansion of the hypertropic chondrocyte zone of
cultured limb explants. Exogenous expression of IGFBP3 and
IGFBP4, but not IGFBP5, leads to inhibition of the IGF-2 effect on
BMP-9-induced ALP activity and matrix mineralization in MSCs.
Furthermore, IGF-2 is shown to enhance the BMP-9-induced
BMPR-Smad reporter activity and the nuclear translocation of
Smad1/5/8. While BMP9 stimulation does not significantly
induce AKT phosphorylation, PI3K inhibitor LY294002 abolishes
the IGF2 potentiation effect on BMP9-mediated osteogenic
signaling, and can directly inhibit BMP9 activity, suggesting that
BMP-9 may crosstalk with IGF-2 through the PI3K/AKT signaling
pathway during osteogenic differentiation of MSCs.
Materials and Methods
Cell culture and chemicals
HEK293, C3H10T1/2, and C2C12 cells were obtained from ATCC
(Manassas,VA,USA).Celllinesweremaintainedunderconditions
as described previouslyy.
(16,18,22,31,32) Unless indicated otherwise,
all chemicals were purchased from Sigma-Aldrich (St Louis, MO,
USA) or Fisher Scientific (Pittsburgh, PA, USA).
Recombinant adenoviruses expressing RFP, GFP, BMP9,
IGF2, IGFBP3, IGFBP4, and IGFBP5
Recombinant adenoviruses were generated using AdEasy
technology, as described previously.
(16,17,33–35) The coding
regions of human BMP9, IGF2, IGFBP3, IGFBP4, and IGFBP5 were
PCR amplified and cloned into an adenoviral shuttle vector and
subsequently used to generate recombinant adenoviruses in
HEK293 cells. The resulting adenoviruses were designated as
AdBMP9, AdR-IGF2, AdR-IGFBP3, AdR-IGFBP4, and AdR-IGFBP5.
AdBMP9 also expresses GFP, whereas AdR-IGF2, AdR-IGFBP3,
AdR-IGFBP4, and AdR-IGFBP5 express RFP as a marker for
monitoring infection efficiency. Analogous adenovirus expres-
sing only monomeric RFP (AdRFP) or GFP (AdGFP) were used as
controls.
(19–22,33,35–38)
Isolation of mouse embryo fibroblasts (MEFs)
MEFs were isolated from postcoitus day 13.5 mice, as described
previously.
(21,22) Each embryo was dissected into 10mL of
sterile PBS, voided of its internal organs, and sheared through an
18-gauge syringe in the presence of 1mL of 0.25% trypsin and
1mM EDTA. After 15minutes of incubation with gentle shaking
at 378C, DMEM with 10% fetal calf serum (FCS) was added to
inactivate trypsin. The cells were plated on 100-mm dishes and
incubated for 24hours at 378C. Adherent cells were used as MEF
cells. Aliquots were kept in a liquid nitrogen tank. All MEFs used
in this study were within five passages.
RNA isolation and semiquantitative RT-PCR analysis
TotalRNAwasisolatedusingTRIZOLReagents(Invitrogen,Carlsbad,
CA, USA). Total RNA was used to generate cDNA templates by RT
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strandcDNAproductswerefurtherdiluted5-to10-foldandusedas
PCR templates. Semiquantitative RT-PCR was carried out as
described previously.
(21,22,31,34,38–41) PCR primers (Supplemental
Table S1) were designed by using the Primer3 program (Free
SoftwareFoundation,Inc.,Boston,MA,USA)toamplifythegenesof
interest (approximately 150 to 180 bp). A touchdown cycling
program was as follows: 948C for 2 minute for 1 cycle, 928Cf o r
20seconds, 688C for 30seconds, and 728C for 12 cycles with a
decreasein18Cpercycleandthenat928Cfor20seconds,578Cfo r
30seconds,and728Cfor20secondsfor20to25cyclesdepending
onthe abundanceofagiven gene. Thespecificity ofPCRproducts
wasconfirmedbyresolvingPCRproductson1.5%agarosegels.All
samples were normalized by the expression level of GAPDH.
Alkaline phosphatase (ALP) assay
ALP activity was assessed by a modified Great Escape SEAP
Chemiluminescence Assay (BD Clontech, Mountain View, CA,
USA) and/or histochemical staining assay (using a mixture of
0.1mg/mL of napthol AS-MX phosphate and 0.6mg/mL of Fast
Blue BB salt), as described previously.
(16,17,19–22,31,34,38) For the
chemilluminescenceassays,eachassayconditionwasperformed
in triplicate, and the results were repeated in at least three
independent experiments. ALP activity was normalized by total
cellular protein concentrations among the samples.
Transfection and luciferase reporter assay
Exponentially growing cells were seeded in 25-cm
2 cell culture
flasks and transfected with 2mg per flask of BMP Smad-
responsive luciferase reporter
(42) p12xSBE-Luc using LipofectA-
mine (Invitrogen). At 16hours after transfection, cells were
replated to 24-well plates and infected with AdBMP9, AdR-IGF2,
and/or AdRFP at 4hours after replating. At 24hours after
infection, cells were lysed, and cell lysates were collected for
luciferaseassaysusingPromega’sLuciferaseAssayKit.Eachassay
condition was performed in triplicate. The results were repeated
in at least three independent experiments. Luciferase activity
was normalized by total cellular protein concentrations among
the samples. Reporter activity was expressed as mean SD.
Matrix mineralization assay (alizarin red S staining)
C3H10T1/2 cells and MEFs were seeded in 24-well culture plates
and infected with AdGFP, AdBMP9, and/or AdR-IGF2. Infected
cells were cultured in the presence of ascorbic acid (50 mg/mL)
and b-glycerophosphate (10mM). At 14 days after infection,
mineralized matrix nodules were stained for calcium precipi-
tation by means of alizarin red S staining, as described
previously.
(16,17,19–22,31,34,38) Cells were fixed with 0.05% (v/v)
glutaraldehyde at room temperature for 10minutes. After
being washed with distilled water, fixed cells were incubated
with 0.4% alizarin red S (Sigma-Aldrich) for 5 minutes, followed
by extensive washing with distilled water. The staining of
calcium mineral deposits was recorded under bright-field
microscopy.
Immunohistochemical staining
Cultured cells were infected with adenoviruses. At the indicated
time points, cells were fixed with 10% formalin and washed with
PBS. The fixed cells were permeabilized with 1% NP-40 and
blocked with 10% goat serum, followed by incubation with an
antiosteocalcin,osteopontin,Smad1/5/8,orp-AKT1/2/3(Ser-473)
antibody (all from Santa Cruz Biotechnology, Santa Cruz, CA,
USA) for 1 hour. After washing, cells were incubated with biotin-
labeled secondary antibody for 30minutes, followed by
incubating cells with streptavidin–horseradish peroxidase
(HRP) conjugate for 20minutes at room temperature. The
presence of the expected protein was visualized by 3,30-
Diaminobenzidine (DAB) staining and examined under a
microscope. Stains without the primary antibody or with control
IgG were used as negative controls.
Subcutaneous stem cell implantation
C3H10T1/2 cellswereinfected withadenoviruses as indicated. At
16hours afterinfection,cells wereharvested andresuspended in
PBS for subcutaneous injection (5 10
6/injection) into the flanks
of athymic nude (nu/nu) mice (five animals per group, 4- to 6-
week old males, Harlan Sprague-Dawley, Indianapolis, IN, USA).
At 5 weeks after implantation, animals were euthanized, and the
implantation sites were retrieved for histologic evaluation and
other stains.
Fetal limb explant culture
The skinned forelimbs of mouse embryos (E18.5) were dissected
under sterile conditions and incubated in DMEM (Invitrogen)
containing 0.5% bovine serum albumin (BSA, Sigma), 50mg/mL of
ascorbic acid (Sigma), 1mM b-glycerophosphate, and 100mg/mL
of penicillin-streptomycin (Mediatech, Manassas, VA, USA) solu-
tion at 378C in humidified air with 5% CO2 for up to 14 days. The
limb explants were directly infected by AdR-IGF2 and/or AdBMP9
one day after dissection. Then 100mM calcein (Sigma) was added
in themediumonthesameday.Themediumwaschangedinhalf
volume onday 7. Cultured tissues were observed at different time
points under the microscope to confirm the survival of tissue cells
and the expression of fluorescence markers.
Micro–computed tomographic (mCT) imaging analysis
All specimens were imaged using the mCT component of a GE
Triumph (GE Healthcare, Piscataway, NJ, USA) trimodality
preclinical imaging system. All image data analysis was
performed using Amira 5.2 (Visage Imaging, Inc., San Diego,
CA, USA), and 3D volumetric data were obtained.
Histologic evaluation and trichrome staining
Retrieved and cultured tissues were fixed in 10% formalin
(decalcified, if necessary) and embedded in paraffin. Serial
sections of the embedded specimens were stained with
hematoxylin and eosin. Paraffin-embedded sections were
deparaffinized and then rehydrated in a graduated fashion.
The deparaffinized samples were subjected to antigen retrieval
and fixation. The sections were stained with hematoxylin and
eosin (H&E) and Masson’s trichrome.
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The image analysis software ImageJ (http://rsbweb.nih.gov/ij/
download.html) was used to analyze the regions of interest and/
or intensity of the acquired image data. Random sampling of 10
to 20 fields were used routinely to determine mean SD values
for statistical analysis.
Statistical analysis
Microsoft Excel was used to calculate standard deviations (SDs)
and statistically significant differences between samples using
the two-tailed Student’s t test. For all quantitative assays, each
assay condition was performed in triplicate, and the results were
repeated in at least three independent experiments. All data
collected were subjected to statistical analysis. A p-value of less
than .05 was defined as statistically significance.
Results
Endogenous IGF-2 expression is low in mesenchymal
stem cells, and exogenous IGF-2 expression potentiates
BMP-9-induced early osteogenic marker ALP activity
In order to determine the effect of IGF-2 on BMP-9-induced
osteogenic differentiation and bone formation, we first
examined the endogenous expression level of IGF-2 on
mesenchymal progenitor cells. Using semiquantitative RT-PCR,
we found that IGF-2 expression level was undetectable in
C3H10T1/2 cells, mouse embryonic fibroblasts (MEFs), and
C2C12 cells (Fig.1A).However, underthe sameRT-PCRcondition,
the endogenous expression of BMP-9 was seemingly low but
detectable, particularly in C3H10T1/2 and C2C12 cells. These
results suggest that IGF-2 expression may be very low in MSCs.
To express exogenous IGF-2 effectively in MSCs, we con-
structed and generated a recombinant adenovirus-expressing
Fig. 1. Potentiationof BMP-9-induced earlyosteogenic markerALP activityin mesenchymal stemcells by IGF-2.(A) Endogenous expression ofBMP-9 and
IGF-2inmesenchymalprogenitorcells.TotalRNAwasisolatedfromC3H10T1/2cells,MEFs,andC2C12cells.SemiquantitativeRT-PCRwasperformedusing
primers specific for mouse GAPDH, mouse BMP9, and mouse IGF2. The PCR products were resolved on 1% agarose gels and visualized under an ultraviolet
lamp. (B) Exogenous expression of IGF-2 mediated by adenovirus-expressing human IGF-2. C3H10T1/2 cells were infected with AdR-IGF2 or Ad-RFP. Total
RNA was isolated on days 1, 2, and 3 after infection and subjected to RT-PCR reactions. Exogenous expression of human IGF-2 was assessed by
semiquantitative RT-PCR using primer pairs specific for human IGF2. The PCR products were resolved on 1% agarose gels and visualized under an
ultraviolet lamp. (C) AdR-IGF2-mediated efficient transduction of MSCs. Subconfluent C3H10T1/2 and MEF cells were infected with recombinant
adenovirus expressing human IGF-2 (AdR-IGF2) at a multiplicity of infection (MOI) of 10. The expression of marker gene monomeric RFP was detected at
36hours after infection under both bright and fluorescence fields. (D) IGF-2 potentiates BMP-9-induced ALP activity in a dose-dependent fashion.
C3H10T1/2 cells were coinfected with AdBMP9 and AdR-IGF2 at MOIs of 20 (high), 10 (medium), and 5 (low) dosages or GFP. ALP activity was measured at
the indicated time points. Each assay condition was done in triplicate.
2450 Journal of Bone and Mineral Research CHEN ET AL.human IGF-2 (ie, AdR-IGF2) using our previously developed
AdEasy system.
(33,35,43) As shown in Fig. 1B, IGF-2 expression was
readily detected in AdR-IGF2 but not in Ad-RFP-infected
C3H10T1/2 cells. Moreover, AdR-IGF2 was shown to effectively
transduce C3H10T1/2 cells and MEFs (Fig. 1C).
We next tested the effect of exogenous IGF-2 on BMP-9-
induced osteogenic differentiation of MSCs. Subconfluent
C3H10T1/2 cells were coinfected with AdGFP, AdBMP9, and/or
AdR-IGF2 (at high, medium, and low dosages). The activity of the
well-established early osteogenic marker alkaline phosphatase
(ALP)
(16–20,22) was measured on days 5, 7, and 9 after infection.
IGF-2 expression alone did not induce any detectable ALP
activity over the GFP control (Fig. 1D). As expected, BMP-9
induced a significant increase in ALP activity, especially on day 9
(Fig. 1D). When BMP-9 expression was fixed, an increase in IGF-2
expression significantly induced an increase in ALP activity
(Fig. 1D). Thus these results strongly indicate that IGF-2 can
potentiate BMP-9-induced osteogenic differentiation in a dose-
dependent fashion.
Exogenous IGF-2 expression enhances BMP-9-induced
late osteogenic marker expression and matrix
mineralization
We further determined the effect of IGF-2 on the BMP-9-induced
late stage of osteogenic differentiation. Both osteopontin and
osteocalcin are well-established markers of late-stage bone
formation.
(16–20,22) We infected C3H10T1/2 cells with AdGFP,
AdBMP9, and/or AdR-IGF2. The infected cells were fixed 10 days
after infection and subjected to immunohistochemical staining
using osteocalcin and osteopontin antibodies. Osteocalcin
expression was detected in BMP-9- and BMP-9/IGF-2-transduced
cells, whereas a higher than basal level staining was observed in
IGF-2-stimulated cells (Fig. 2A). Osteopontin expression was
Fig. 2. Augmentation of BMP-9-induced late osteogenic markers by IGF-2. (A) Immunohistochemical staining of osteocalcin. C3H10T1/2 cells were
infectedwith adenoviruses as indicated.Expressionof osteocalcin wasassessedby immunohistochemicalstaininganalysisat 10days afterinfectionusing
an antiosteocalcin antibody (Santa Cruz Biotechnology). (B) Immunohistochemical staining of osteopontin. C3H10T1/2 cells were infected with
adenoviruses as indicated. Expression of osteopontin was assessed by immunohistochemical staining analysis at 10 days after infection using an
antiosteopontinantibody(SantaCruzBiotechnology).(C)AlizarinredSstaining.C3H10T1/2cellswereinfectedwithadenovirusesasindicated.Alizarinred
S staining was conducted at 14 days after infection.
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in BMP-9- or IGF-2-stimulated cells (Fig. 2B). We also examined
the effect of IGF-2 on BMP-9-induced matrix mineralization in
MSCs. C3H10T1/2 cells were infected with AdGFP, AdBMP9, and/
or AdR-IGF2. At 14 days after infection, the infected cells were
subjected to alizarin red S staining. Numerous mineralization
nodules were readily detected in BMP-9/IGF-2-stimulated cells,
whereas a significant number of nodules also were found in
BMP-9-transduced 3H10T1/2 cells (Fig. 2C). These findings
strongly suggest that while IGF-2 itself has very limited ability
to induce the late stage of bone formation, a combination of
BMP-9 and IGF-2 significantly promotes the BMP-9-induced late
stage of osteogenic differentiation in vitro.
IGF-2 expression augments BMP-9-induced ectopic bone
formation and matrix mineralization in MSC implantation
in vivo
Using our previously established stem cell implantation assay,
we tested the effect of IGF-2 on BMP-9-induced ectopic bone
formation in vivo. C3H10T1/2 cells were shown to be effectively
coinfected with AdRFP, AdBMP9, and/or AdR-IGF2 (Fig. 3A). The
infected cells were collected and injected subcutaneously into
athymic nude mice. At week 5, the animals were euthanized, and
the bony masses were retrieved (Fig. 3B). Consistent with our
earlier reports, C3H10T1/2 cells transduced with either RFP or
IGF-2 alone did not form any detectable masses (data not
shown). The BMP-9-transduced cells formed bony masses, which
were noticeably smaller than those formed by the cells
transduced by both BMP-9 and IGF-2 (Fig. 3B). On histologic
examination, bone masses formed in the BMP-9-transduced cell
group showed some mature bone matrices and trabeculae with
the presence of a significant number of undifferentiated
mesenchymal progenitor cells (Figs. 3C, E). On the other hand,
cells stimulated by both BMP-9 and IGF-2 formed more mature
bone matrices and thicker trabeculae, with minimal or residual
undifferentiated mesenchymal progenitor cells (Fig. 3C). Mas-
son’s trichrome staining confirmed that IGF-2 significantly
augmented BMP-9-induced matrix mineralization (Fig. 3D, E).
The preceding in vivo results further confirmed the in vitro
findings presented in Fig. 1D and Fig. 2, suggesting that IGF-2
may be able to potentiate osteogenic differentiation of MSCs
induced by BMP-9.
IGF-2 promotes expansion of the hypertrophic
chondrocyte zone and enhances BMP-9-induced
endochondral ossification in fetal limb explant culture
IGF-2 signaling plays an important role in development.
(28) We
examined the effect of IGF-2 on skeletal development in fetal
limb explant culture in the presence or absence of BMP-9.
Perinatal E18.5 mouse embryos were harvested. The skinned
fetal limbs were isolated and cultured in organ culture medium
(Fig. 4A, i). The soft tissues associated with the cultured limb
expants were infected with adenovirus expressing GFP (Fig. 4A,
ii) or RFP (Fig. 4A, iii). The new bone formation was traced by the
green fluorescence dye calcein (Fig. 4A, iv). When the limb
explants were stimulated with GFP, IGF-2, and/or BMP-9 for
2 weeks, significant new bone formation (in the fourth
metacarpal) was found in the limb explants infected with
AdBMP9 and AdBMP9/AdR-IGF2, whereas the BMP-9/IGF-2-
stimulated limb explants had the highest level of new bone
formation, as judged by the calcein uptake (Fig. 4B). Histologic
examination confirmed that increased endochondral ossification
in BMP-9 and BMP-9/IGF-2 stimulated explants (Fig. 4C).
At a higher magnification, either BMP-9 or IGF-2 stimulation
significantly expanded the hypertrophic chondrocyte zone
compared with that of the GFP control (Fig. 4D). These organ
culture studies strongly suggest that IGF-2 may promote
expansion of the hypertrophic chondrocyte zone and enhance
BMP-9-induced endochondral ossification.
IGFBP3 and IGFBP4 antagonize the effect of IGF-2 on
BMP-9-induced osteogenic differentiation of MSCs
IGF-2 signaling can be negatively regulated by IGFBPs. We
analyzed the endogenous expression level of three IGFBPs.
We found that IGFBP3 was highly expressed in MEFs but
undetectable in both C3H10T1/2 and C2C12 cells (Fig. 5A).
IGFBP4 was highly expressed in MEFs, whereas it was barely
detectable in C3H10T1/2 and C2C12 cells (Fig. 5A). IGFBP5
expression was low or detectable in all three lines examined
(Fig. 5A). These results indicate that the expression pattern of the
three IGFBPs is different in the two progenitor lines C3H10T1/2
and C2C12 from that in the pool population of MEFs.
We next analyzed whether IGFBPs would antagonize IGF-2’s
effect on BMP-9-induced osteogenic differentiation. C3H10T1/2
cells were infected with AdGFP, AdR-IGF2, and/or AdBMP9 in the
presence or absence of IGFBPs. At 7 or 9 days after infection,
cells were collected and subjected to ALP activity assay. Both
IGFBP3andIGFBP4wereshowntoinhibitIGF-2-enhancedBMP-9
osteogenic activity, whereas IGFBP5 exerted a minimal or
insignificant inhibitory effect on IGF-2/BMP-9-induced osteo-
genic differentiation of C3H10T1/2 cells (Fig. 5B). A similar result
also was found in alizarin red S staining assay because IGFBP3
and IGFBP4 were shown to inhibit BMP-9/IGF-2-induced matrix
mineralization (Fig. 5C). In both assays, IGFBP4 was seemingly
the strongest inhibitor of IGF-2’s effect on BMP-9 osteogenic
signaling. These results suggest that among the IGFBPs, IGFBP3
and IGFBP4 may be able to inhibit IGF-2-enhanced BMP-9-
induced osteogenic differentiation.
IGF-2 acts synergistically with BMP-9 in activating
Smad signaling activity
To investigate the mechanism behind IGF2’s effect on BMP-9-
induced osteogenic signaling, we examined whether IGF-2
affected BMP-9 function at the Smad signaling level. We
transfected C3H10T1/2 cells with a previously reported BMPR-
Smad luciferasereporter, p12xSBE-Luc
(42), andinfected withGFP,
IGF-2, and/or BMP-9 adenoviruses. As expected, BMP-9 was
shown to significantly upregulate the BMPR-Smad reporter
activity, whereas IGF-2 alone did not significantly activate BMPR-
Smad reporter activity (Fig. 6A). However, IGF-2 was shown to
effectively enhanceBMP-9-induced BMPR-Smadreporter activity
(Fig. 6A). Consistent with the results from R-Smad reporter assay,
BMP-9 was shown to induce nuclear translocation of Smad1/5/8,
which was further augmented by IGF-2 (Fig. 6B). IGF-2 alone
2452 Journal of Bone and Mineral Research CHEN ET AL.Fig. 3. IGF-2 enhances BMP-9-induced ectopic bone formation. (A) Efficient transduction of MSCs via coinfection. Subconfluent C3H10T1/2 cells were
coinfected with BMP-9 (GFP) and IGF-2 (RFP) adenoviruses or other combinations. Fluorescence images were recorded at 24hours after infection.
Representative images are shown. (B) Macrographic images of ectopic bone mass. BMP-9- or BMP-9/IGF-2-expressing MSCs were implanted
subcutaneously. Ectopic osseous masses were retrieved at 5 weeks. Representative images from injection pairs are shown. Quantitative analysis of
thebonymassesalsowasdoneusingmCTimaginganalysis.(C) Histologicevaluationoftheretrievedbonemasses.RetrievedbonemassesfromBMP-9-or
BMP-9/IGF-2-treated groups were fixed and decalcified. The paraffin-embedded sections were subjected to hematoxylin and eosine (H&E) staining.
Representative images are shown. Magnification,  300. (D) Masson’s trichrome staining of the bone masses. The tissue sections prepared in panel C were
subjectedto Masson’strichrome staining.Representative imagesare shown. Magnification,  300. (E) Quantitative analysis of percent trabecular area over
total area and average trabecular thickness was done by using ImageJ. At least 10 samples (with  40 magnification) from each group were randomly
selected and analyzed using ImageJ software. AC¼adipocyte; MBM¼mineralized bone matrix; OB¼osteoblast; OC¼osteocyte; UM¼undifferentiated MSCs.
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(Fig. 6B). These results strongly suggest that IGF-2 may exhibit its
stimulatory effect on BMP-9 signaling by modulating BMPR-
Smad transcriptional activity.
BMP-9 crosstalks with IGF-2 through the PI3K/AKT
signaling pathway in MSCs
IGF-2 transduces its signaling through activation of the PI3K/AKT
pathway. We sought to test whether BMP-9 crosstalks with IGF-2
through the PI3K/AKT pathway. When C3H10T1/2 cells were
stimulated with GFP, IGF-2, and/or BMP-9 and subjected to
immunohistochemical staining, the phosphorylated form of
AKT1/2/3(Ser-473)wasdetectedinIGF-2-stimulatedcellsbutnot
apparently in the control or BMP-9-stimulated cells (Fig. 6C).
However, the phosphorylated AKT1/2/3 was most pronounced
in the cells stimulated by both IGF-2 and BMP-9 (Fig. 6C),
suggesting that there may be crosstalk between the BMP-9 and
IGF-2 pathways.
Since AKT is regulated by PI3K, we further tested whether
IGF-2-activated PI3K activity plays any role in BMP-9 signaling.
Using a well-established PI3K inhibitor, LY294002, we infected
C3H10T1/2 cells with GFP, BMP-9, and/or IGF-2 and treated them
with LY294002 for 7 and 9 days. We found that the PI3K inhibitor
LY294002 effectively inhibited the ALP activity in the cells
stimulated by BMP-9 and IGF-2 (Fig. 6D). Interestingly, LY294002
also was shown to inhibit BMP-9-induced ALP activity (Fig. 6D,
and data not shown), suggesting that PI3K may cross-regulate
BMP-9-mediated osteogenic signaling.
Discussion
In this study, we analyzed the effect of IGF-2 on BMP-9-induced
bone formation. Through a comprehensive analysis of the 14
typesofBMPs,wepreviouslyfoundthatBMP-9isoneofthemost
osteogenic BMPs both in vitro and in vivo.
(11,16–22) Our findings
strongly suggest that BMP-9 may be used as an efficacious bone-
regeneration agent. Nonetheless, it is conceivable that more
efficacious bone regeneration may be achieved if BMP-9 is
administered with other growth factors, such as IGF-2. Here we
have found that endogenous IGF-2 expression is relatively low in
MSCs. Exogenous expression of IGF-2 can potentiate BMP-9-
induced activity of the early osteogenic marker ALP and the
expression of later markers such as OC and OPN in MSCs. IGF-2 is
shown to augment BMP-9-induced ectopic bone formation in
Fig. 4. IGF-2 promotes expansion of the hypertrophic chondrocyte zone and enhances BMP-9-induced endochondral ossification in organ culture.
(A) Harvest, transduction, and labeling of mouse E18.5 forelimbs (n¼8 each group). The E18.5 forelimbs were dissected, and the skin was removed with
the soft tissues attached. The recombinant adenovirus (5 10
10 pfu in 1mL of medium) expressing GFP or RFP was added to culture medium. Bright-field
(i), GFP fluorescence (ii), and RFP fluorescence (iii) images were taken at 36hours after infection. The mineralization-labeling fluorescence dye calcein
(0.5mg/mL) was added to the medium, and green fluorescence signal was recorded at 24hours after labeling (iv). (B) New bone formation of the cultured
forelimbs stimulated with BMP-9 and/or IGF-2 at week 2. The dissected forelimb culture was infected with AdBMP9, AdGFP, AdR-IGF2, or AdBMP9/AdR-
IGF2 for 2 weeks. Calcein (0.5mg/mL) was added to the medium at 24hours prior to harvest. The tissues were subjected to frozen section. The green
fluorescence (calcein staining) signal from the fourth metacarpal of the cultured limbs is shown. Quantitative analysis of bone-forming activity (based on
calceinincorporation)alsowasconductedbyusingImageJ.(C,D)Histologicevaluation.TheprecedingfrozensectionsweresubjectedtoH&Estainingand
recordedunderbrightfieldwith 40magnification(C)and 400magnification(D).Theaveragelengthofthehypertrophiczonesalsowasdeterminedby
using ImageJ. HC¼hypertrophic chondrocyte zone; PC¼proliferating chondrocyte zone (partial).
2454 Journal of Bone and Mineral Research CHEN ET AL.our stem cell implantation assay. We have further demonstrated
that IGF-2 enhances BMP-9-induced endochondral ossification,
whereas IGF-2 itself can promote expansion of the hypertropic
chondrocyte zone of the cultured limb explants. IGFBP3 and
IGFBP4 can inhibit the IGF-2 effect on BMP-9-induced ALP
activity and matrix mineralization in MSCs. IGF-2 is shown to
enhance the BMP-9-induced BMPR-Smad reporter activity and
the nuclear translocation of Smad1/5/8. PI3K inhibitor LY294002
abolishes the IGF-2 potentiation effect on BMP-9-mediated
osteogenic signaling and can directly inhibit BMP-9 activity,
suggesting that BMP-9 may crosstalk with IGF-2 through the
PI3K/AKT signaling pathway during osteogenic differentiation of
MSCs.
The IGF system consists of three ligands (IGF-1, IGF-2, and
insulin), four cell-membrane receptors [IGF receptor type 1 (IGF-
1R), insulin receptor isoform A (IR-A), hybrid receptors, and IGF
receptor type 2 (IGF-2R)], and six IGF-binding proteins (IGFBP1
through -6).
(27) It has been reported that TGF-b regulates IGFBP4
proteolysis in osteoblasts, which depends on IGF-2, suggesting
that local TGF-b and IGF-2 in the bone microenvironment
coordinately amplify IGF-1 bioavailability through controlled
IGFBP4 proteolysis to promote bone formation.
(44) This is
supported by an earlier study in which systemic administration
of IGFBP4 increased bone-formation parameters in mice by
increasing IGF bioavailability in the circulation via an IGFBP-4
protease–dependent mechanism.
(45) However, paracrine over-
expression of IGFBP4 in osteoblasts of transgenic mice decreases
bone turnover and causes global growth retardation.
(46) As a
member of the IGF signaling system, IGF-2 plays an important
role in prenatal growth and postnatal development. IGF-2
transduces its signaling through IGF receptors and activates the
PI3K/AKT pathway or the MAPK pathway.
(27) Although viable and
fertile, Igf2 null mice exhibit a 40% decrease in birth weight
compared with their wild-type littermates, suggesting an
important role of IGF-2 in development.
The IGF2 gene is imprinted and expressed only from the
paternal allele in the placenta and fetal tissues, excluding the
brain.
(47) IGF2 expression becomes biallelic in tissues in humans,
but not rodents, after birth. Imprinting of the IGF2 gene is
controlled in part by the H19DMR (differentially methylated
region) gene, which plays an important role in parent-of-origin-
specific silencing of neighboring H19 and IGF2. There are
ontogenetic shifts in IGF2 imprinting and IGF promoter usage
that may influence IGF bioavailability in placental and fetal
tissues at critical stages of development.
(48,49) Loss of imprinting
(LOI) of IGF2 is strongly associated with cell proliferation and in
manycaseswith humanmalignancies, includingsome sarcomas.
The excess of IGF-2 in mice causes somatic overgrowth,
visceromegaly, placentomegaly, omphalocele, and cardiac and
adrenal defects, which are also features of the Beckwith-
Fig. 5. Inhibition of IGF-2-enhanced BMP-9-induced osteogenic differentiation by IGFBP3 and IGFBP4. (A) Endogenous expression of IGFBPs in MSCs.
Total RNA was isolated from C3H10T1/2 cells, MEFs, and C2C12 cells and subjected to semiquantitative RT-PCR analysis using primers specific for mouse
GAPDH, IGFBP3, IGFBP4, and IGFBP5. PCR products were resolved on 1.2% agarose gels. Representative data are shown. (B) IGFBP3 and IGFBP4 antagonize
IGF-2-enhanced ALP activity induced by BMP-9. Subconfluent C3H10T1/2 cells were coinfected with adenoviruses expressing IGF2, BMP9, IGFBPs, and/or
GFP. ALP activity was assessed on days 7 and 9. Each assay condition was done in triplicate. (C) IGFBP3 and IGFBP4 antagonize IGF-2-enhanced matrix
mineralization induced by BMP-9. Subconfluent C3H10T1/2 cells were coinfected with adenoviruses expressing IGF2, BMP9, IGFBPs, and/or GFP in the
presence of mineralization medium. Alizarin red S staining was performed on day 14. Representative data are shown.
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associated with chromosomal abnormalities in the 11p15.5
region where the IGF2 gene resides.
(50) Mouse chimeras made
with androgenetic (two paternal genomes) ova or embryonic
stem cells frequently die at the perinatal stage and exhibit a
range of defects, with the most noticeable being a pronounced
overgrowth of rib cartilage, whole-body overgrowth, and
perinatal death.
(51) It has been reported that hypoxic stress
enhanced osteoclast differentiation via increasing IGF-2 produc-
tion by nonosteoclastic cells. The upregulation of IGF-2 derived
from nonosteoclastic cells may be a crucial factor for osteoclast
differentiation.
(52) Furthermore, it has been reported that the
local production of IGF-2 may modulate both osteoblast-
osteoclast interactions and osteoclast formation and may play
an important role in bone remodeling.
(52) It has been reported
recently that IGF-1 and BMP-2 can act synergistically in
promoting chondrogenesis.
(53,54) However, the molecular
mechanisms of the IGF-2 stimulation that enhance osteoclast
formation remain unknown.
IGF bioavailability is tightly controlled by IGFBPs, which are a
familyofsixhomologousmultifunctional high-affinityproteinsin
the circulation. IGFBPs are mostly inhibitory to IGF actions but
also have IGF-independent actions.
(28) In the circulation, IGF-2 is
bound mainly to IGFBP3, which is the most abundant IGFBP in
serum. At the cellular level, the interaction of IGFs with their
receptors is influenced by the presence of IGFBPs. Depending on
the cellular context and the IGFBP present, the actions of IGFs
can be either enhanced or inhibited. IGF-binding capacity of
IGFBPs is regulated by the presence of a wide range of
proteolytic enzymes. Increasing evidence suggests that IGFBPs
also have IGF-independent functions. For example, IGFBP3 itself
has a proapoptotic function, whereas IGFBP5 has a significant
influence on bone mineral density (BMD) acquisition and
maintenance in a gender- and age-dependent fashion, which
may have implications for the gender-biased progression of
osteoporosis.
(55) Our results have demonstrated that IGFBP3 and
IGFBP4, but not IGFBP5, can antagonize IGF-2 action on BMP-9-
induced osteogenic differentiation. It was reported that IGFBP5
Fig. 6. IGF-2-activated PI3K/AKT pathway crosstalks with BMP-9-mediated osteogenic signaling. (A) Effect of IGF-2- and BMP-9-induced BMPR-Smad
reporter activity. Subconfluent C3H10T1/2 cells were seeded in 25-cm
2 flasks and transfected with 2mg per flask of the BMPR-Samd-responsive luciferase
reporter p12xSBE-Lucusing LipofectAmine(Invitrogen).At 16hours after transfection, cellswere replatedto 24-wellplates and wereinfected with AdGFP,
AdBMP9, and/or AdR-IGF2 at 4hours after replating. At 24 to 48hours after infection, cells were lysed, and cell lysates were collected for luciferase assays
using Promega’s Luciferase Assay Kit. Each assay condition was performed in triplicate. (B) IGF-2 promotes BMP-9-induced nuclear localization of BMPR-
Smads. Subconfluent C3H10T1/2 cells were infected with GFP, IGF2, and/or BMP9 for 16hours. Cells were fixed and subjected to immunohistochemical
staining using an anti-Smad1/5/8 antibody. Positive nuclear staining is indicated by arrows. Representative data are shown. (C) BMP-9 promotes IGF-2-
induced phoshporylation of AKT. Subconfluent C3H10T1/2 cells were infected with AdGFP, AdR-IGF2, and/or AdBMP9 for 16hours. Cells were fixed and
subjected to immunohistochemical staining using an anti-p-AKT1/2/3 (Ser-473) antibody. Positive nuclear staining is indicated by arrows. Representative
dataareshown.(D) InhibitionofIGF-2-potentiatedBMP-9-induced ALPactivitybyPI3K inhibitor.Subconfluent C3H10T1/2 cellswereinfectedwith AdGFP,
AdR-IGF2, and/or AdBMP9. The PI3K inhibitor LY294002 (20mM; BIOMOL, Plymouth Meeting, PA, USA) was added to AdR-IGF2/AdBMP9-transduced cells.
At the indicated time points, ALP activity was determined. Each assay condition was done in triplicate.
2456 Journal of Bone and Mineral Research CHEN ET AL.inhibits osteoblast differentiation and skeletal growth by
blocking IGF actions.
(56) Interestingly, an early report indicated
that IGFBP3 potentiation of IGF action can be mediated through
the PI3K pathway and is associated with alteration in AKT
sensitivity.
(57)
As one of the major pathways involved in IGF signaling, PI3K/
AKTsignaling is implicated in mediating a broad range of cellular
responses, although its role in osteogenesis remains to be fully
understood. In osteoclasts, PI3K functions as a critical down-
stream effecter of c-fms [the receptor for colony-stimulating
factor 1 (CSF-1)], avb3 integrin, and RANK [receptor activator of
nuclear factor kB (NF-kB)], affecting osteoclast survival and
activity. PI3K/AKT signal relay may cooperate with Smad in BMP-
2-induced CSF-1 expression and osteoclast differentiation.
(58)
Recent evidence suggests a role for PI3K/AKT in osteoblast
differentiation and survival. It was reported that BMP-2-induced
PI3K and AKT kinase are required in osteoblast differentiation
and BMP-2/Smad-dependent gene transcription.
(59) Runx2
induces osteoblast and chondrocyte differentiation and
enhances their migration by coupling with PI3K/AKT signal-
ing,
(60) suggesting that Runx2 and PI3K/AKT signaling are
mutually dependent on each other in the regulation of
osteoblast and chondrocyte differentiation. It has been reported
recently that an intact IGF-induced PI3K/AKT signaling cascade is
essential for BMP-2-activated osteoblast differentiation and
maturation, bone development, and growth.
(61–65) Conversely,
mice deficient in a negative regulator of PI3K signaling, the
tumor suppressor PTEN in osteochondroprogenitor cells,
exhibited epiphyseal growth plate abnormalities and skeletal
overgrowth
(66) and demonstrated a dramatic and progressively
increasing BMD throughout life.
(67) Taken together, these
findings are consistent with our current results with the effect
of IGF-2 on BMP-9-mediated osteogenic signaling, suggesting
that manipulations of BMP and IGF pathways could facilitate
bone remodeling and fracture repair.
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